---
id: "quote-disease-borders"
type: "quote"
source_timestamps: ["§ 5. Continue to drive global collaborations.", "¶19"]
tags: ["global-health", "collaboration"]
related: ["action-cross-border-trials"]
speaker: "Authors"
speakers: ["Anaeze C. Offodile II", "Kushal T. Kadakia", "Yashodhara Dash", "Whitney Snider", "Joseph C. Wu", "Selwyn M. Vickers"]
sources: ["tail2"]
sourceVaultSlug: "hbr-seg-tail2"
originDay: 2
articleStem: "hbr-tail-131-medical-drug-discovery"
sourceUrl: "https://hbr.org/2026/04/u-s-medical-centers-need-a-new-model-for-drug-discovery-and-development"
sourceTitle: "U.S. Medical Centers Need a New Model for Drug Discovery and Development"
---
# Disease Knows No Borders

> "Disease knows no borders, which is why many U.S. AMCs have long been engaged in global collaborations."

The rationale for maintaining and expanding international clinical-trial networks despite geopolitical tension — the basis for [[action-cross-border-trials]] (Pillar 5 of [[framework-amc-innovation-acceleration]]). Attributed to the article's authors collectively.